Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Positive Results With Carillon Mitral Device Seen in Real-world Registries

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

February 21, 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

February 13, 2025

Rethinking MR: A Heart Failure Physician's Perspective

Presentation THT 2025

Rethinking MR: A Heart Failure Physician's Perspective

Presenter: Hansie Mathelier

February 12, 2025

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

Presentation THT 2025

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

Presenter: Michael Brener

February 12, 2025

Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations

Presentation THT 2025

Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations

Presenter: Faiez Zannad

February 11, 2025

MRAs Redux: New Evidence in Heart Failure

Presentation THT 2025

MRAs Redux: New Evidence in Heart Failure

Presenter: Scott Solomon

February 11, 2025

Flow Restoration Leads to LV Mass Regression After DurAVR® Biomimetic THV Implant: MRI Study

Presentation THT 2025

Flow Restoration Leads to LV Mass Regression After DurAVR® Biomimetic THV Implant: MRI Study

Presenter: Christopher Meduri

February 11, 2025

Novel Strategies in mRNA Therapeutics for Heart Failure

Presentation THT 2024

Novel Strategies in mRNA Therapeutics for Heart Failure

Presenter: John Cooke

March 05, 2024

How to Manage This Difficult FMR Case?

Presentation THT 2024

How to Manage This Difficult FMR Case?

Presenter: Yogita Rochlani

March 04, 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presentation THT 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presenter: Martin B. Leon

March 04, 2024

Post-TEER Nonresponders: Is Cardiomems a Meaningful Option?

Presentation THT 2024

Post-TEER Nonresponders: Is Cardiomems a Meaningful Option?

Presenter: Nir Uriel

March 04, 2024

Impact of Mitral TEER on Cardiomechanics and Energetics

Presentation THT 2024

Impact of Mitral TEER on Cardiomechanics and Energetics

Presenter: Nicolas M. Van Mieghem

March 04, 2024

Atrial Functional MR: Diagnosis and Therapy Implications

Presentation THT 2024

Atrial Functional MR: Diagnosis and Therapy Implications

Presenter: Federico M. Asch

March 04, 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presentation THT 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presenter: Shmuel Chen

March 04, 2024

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

March 23, 2023

Atrial and Ventricular Functional MR: Treatment Implications

Presentation THT 2023

Atrial and Ventricular Functional MR: Treatment Implications

Presenter: Federico Asch

March 22, 2023

TR Management in the Setting of MR: Lessons From Surgical Experiences

Presentation THT 2023

TR Management in the Setting of MR: Lessons From Surgical Experiences

Presenter: Gorav Ailawadi

March 22, 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

March 21, 2023

Acute MR With MCS/TEER

Presentation THT 2023

Acute MR With MCS/TEER

Presenter: Thomas Waggoner

March 21, 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

March 21, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.